Claire Garwood, PhD
Affiliations: | Sheffield Institute for Translational Neuroscience |
Area:
Alzheimer's diseaseGoogle:
"Claire Garwood"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Matuszyk MM, Garwood CJ, Ferraiuolo L, et al. (2021) Biological and methodological complexities of beta-amyloid peptide: Implications for Alzheimer's disease research. Journal of Neurochemistry |
| de Matos AM, Blázquez-Sánchez MT, Bento-Oliveira A, et al. (2020) Glucosylpolyphenols as inhibitors of Aβ-induced Fyn kinase activation and Tau phosphorylation: synthesis, membrane permeability, and exploratory target assessment within the scope of type 2 diabetes and Alzheimer's disease. Journal of Medicinal Chemistry |
| Chambers A, Bury JJ, Minett T, et al. (2020) Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort. Journal of Neuropathology and Experimental Neurology |
| Fadul MM, Garwood CJ, Waller R, et al. (2020) NDRG2 Expression Correlates with Neurofibrillary Tangles and Microglial Pathology in the Ageing Brain. International Journal of Molecular Sciences. 21 |
| Vazquez-Villaseñor I, Garwood CJ, Heath PR, et al. (2019) Expression of p16 and p21 in the frontal association cortex of ALS/MND brains suggest neuronal cell cycle dysregulation and astrocyte senescence in early stages of the disease. Neuropathology and Applied Neurobiology |
| Matos AM, Man T, Idrissi I, et al. (2019) Discovery of N-methylpiperazinyl flavones as a novel class of compounds with therapeutic potential against Alzheimer’s disease: synthesis, binding affinity towards amyloid β oligomers (Aβo) and ability to disrupt Aβo-PrPC interactions Pure and Applied Chemistry. 91: 1107-1136 |
| Waller R, Murphy M, Garwood CJ, et al. (2018) Metallothionein-I/II expression associates with the astrocyte DNA damage response and not Alzheimer-type pathology in the aging brain. Glia |
| Ratcliffe LE, Vázquez Villaseñor I, Jennings L, et al. (2018) Loss of IGF1R in Human Astrocytes Alters Complex I Activity and Support for Neurons. Neuroscience |
| Garwood CJ, Ratcliffe LE, Simpson JE, et al. (2016) Review: Astrocytes in Alzheimer's disease and other age-associated dementias; a supporting player with a central role. Neuropathology and Applied Neurobiology |
| Simpson JE, Ince PG, Minett T, et al. (2015) Neuronal DNA damage response-associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of Alzheimer-type pathology. Neuropathology and Applied Neurobiology |